{"DataElement":{"publicId":"6741256","version":"1","preferredName":"Cutaneous T-cell Lymphoma Response in Viscera Category","preferredDefinition":"Response category that describes the disease involvement in viscera based on staging and classification criteria for cutaneous T-cell lymphoma (CTCL).","longName":"CTCL_VISCERA_SCR_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6741246","version":"1","preferredName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Global Response in Viscera","preferredDefinition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma._Criteria for the response to treatment in viscera, as a component of global response.","longName":"6741233v1.0:6741244v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6741233","version":"1","preferredName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","preferredDefinition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma.","longName":"C3467","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","conceptCode":"C3467","definition":"A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A32B7-C39E-1131-E053-F662850AA707","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6741244","version":"1","preferredName":"Global Response in Viscera","preferredDefinition":"Criteria for the response to treatment in viscera, as a component of global response.","longName":"C159963","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Response in Viscera","conceptCode":"C159963","definition":"Criteria for the response to treatment in viscera, as a component of global response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A4B23-96CA-2FDC-E053-F662850AC329","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A4B23-96DB-2FDC-E053-F662850AC329","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6741220","version":"1","preferredName":"Global Response in Viscera Category","preferredDefinition":"Criteria for the response to treatment in viscera, as a component of global response._A grouping of items based on some commonality or by user defined characteristics.","longName":"GR_VISCR_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CR","valueDescription":"Global Complete Response in Viscera","ValueMeaning":{"publicId":"6741221","version":"1","preferredName":"Global Complete Response in Viscera","longName":"6741221","preferredDefinition":"Liver or spleen or any organ considered involved at baseline should not be enlarged on physical exam and should be considered normal by imaging; no nodules should be present on imaging of liver or spleen; any post treatment mass must be determined by biopsy to be negative for lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Complete Response in Viscera","conceptCode":"C159964","definition":"Liver or spleen or any organ considered involved at baseline should not be enlarged on physical exam and should be considered normal by imaging; no nodules should be present on imaging of liver or spleen; any post treatment mass must be determined by biopsy to be negative for lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DBEF-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"883A1A6A-DC08-136E-E053-F662850A47AE","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"PD","valueDescription":"Global Progressive Disease in Viscera","ValueMeaning":{"publicId":"6741222","version":"1","preferredName":"Global Progressive Disease in Viscera","longName":"6741222","preferredDefinition":"Greater than 50 percent increase in size by sum of products of diameter (SPD) of any organs involved at baseline; or new organ involvement or loss of response: greater than 50 percent increase from nadir in the size (SPD) of any previous organ involvement in those with partial response (whichever occurs first).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Progressive Disease in Viscera","conceptCode":"C159967","definition":"Greater than 50 percent increase in size by sum of products of diameter (SPD) of any organs involved at baseline; or new organ involvement or loss of response: greater than 50 percent increase from nadir in the size (SPD) of any previous organ involvement in those with partial response (whichever occurs first).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DC14-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"883A1A6A-DC2D-136E-E053-F662850A47AE","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"PR","valueDescription":"Global Partial Response in Viscera","ValueMeaning":{"publicId":"6741223","version":"1","preferredName":"Global Partial Response in Viscera","longName":"6741223","preferredDefinition":"50 percent or greater regression in any splenic or liver nodules, or in measurable disease (sum of products of diameter) in any organs abnormal at baseline; no increase in size of liver or spleen and no new sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Partial Response in Viscera","conceptCode":"C159965","definition":"50 percent or greater regression in any splenic or liver nodules, or in measurable disease (sum of products of diameter) in any organs abnormal at baseline; no increase in size of liver or spleen and no new sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DC39-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"883A1A6A-DC52-136E-E053-F662850A47AE","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"Global Relapse in Viscera","ValueMeaning":{"publicId":"6741224","version":"1","preferredName":"Global Relapse in Viscera","longName":"6741224","preferredDefinition":"New organ involvement in those with complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Relapse in Viscera","conceptCode":"C159968","definition":"New organ involvement in those with complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DC5E-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"883A1A6A-DC77-136E-E053-F662850A47AE","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"},{"value":"SD","valueDescription":"Global Stable Disease in Viscera","ValueMeaning":{"publicId":"6741225","version":"1","preferredName":"Global Stable Disease in Viscera","longName":"6741225","preferredDefinition":"Fails to attain the criteria for complete response, partial response, or progressive disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Stable Disease in Viscera","conceptCode":"C159966","definition":"Fails to attain the criteria for complete response, partial response, or progressive disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DC83-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"883A1A6A-DC9C-136E-E053-F662850A47AE","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6741219","version":"1","preferredName":"Global Response in Viscera Category","preferredDefinition":"Criteria for the response to treatment in viscera, as a component of global response.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C159963:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Global Response in Viscera","conceptCode":"C159963","definition":"Criteria for the response to treatment in viscera, as a component of global response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DBC6-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A1A6A-DBD7-136E-E053-F662850A47AE","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Response in Viscera","type":"Preferred Question Text","description":"Response in Viscera","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A7858-453A-30B4-E053-F662850A9FFC","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-06","modifiedBy":"COOPERM","dateModified":"2019-05-08","changeDescription":"Created for NCI-INC0370865: 19C0076 qns curation request 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}